Literature DB >> 25164207

The influence of aging on the diagnosis of primary aldosteronism.

Chikako Nakama1, Kei Kamide2, Tatsuo Kawai1, Kazuhiro Hongyo1, Norihisa Ito1, Miyuki Onishi1, Yasushi Takeya1, Koichi Yamamoto1, Ken Sugimoto1, Hiromi Rakugi1.   

Abstract

Primary aldosteronism (PA) is common in young or middle-aged hypertensive patients, but PA among the elderly has recently become more common. As salt sensitivity increases with age, plasma renin activity (PRA) tends to decrease, whereas the aldosterone-to-renin ratio (ARR) tends to increase in the elderly. The aim of this study was to clarify the influence of aging on the diagnosis of PA. We retrospectively evaluated 155 consecutively admitted patients who were not taking antihypertensive medications or calcium channel blockers and α blockers that underwent PRA and plasma aldosterone concentration (PAC) measurements. The study subjects included 13 PA and 69 essential hypertensive (EHT) patients aged over 65 years, and 32 PA and 41 EHT patients under aged 65 years. Our study clarified the influence of aging through screening and confirmatory tests for the diagnosis of PA. Our results showed the ARR cutoff value for a screening test to be 556 (area under the curve: AUC=0.906), its sensitivity and specificity to be 84.6% and 89.9%, respectively, and the likelihood ratio to be 8.34 in the elderly, whereas the ARR cutoff value was 272 in the non-elderly. In the saline infusion test, the mean PAC was 86.6 ± 41.8 pg ml(-1) in the elderly and 158.1 ± 116.5 pg ml(-1) in the non-elderly (P = 0.04). There was no influence from age in both the captopril challenge test and the furosemide upright test. Aging may influence PA screening and saline infusion tests; thus, we should consider the influence of aging in the diagnosis of elderly subjects with PA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25164207     DOI: 10.1038/hr.2014.129

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  9 in total

1.  Potential effects of age on screening for primary aldosteronism.

Authors:  Q Luo; N F Li; X G Yao; D L Zhang; S F Y Abulikemu; G J Chang; K M Zhou; G L Wang; M H Wang; W J Ouyang; Q Y Cheng; Y Jia
Journal:  J Hum Hypertens       Date:  2015-04-16       Impact factor: 3.012

2.  Performance of Confirmatory Tests for Diagnosing Primary Aldosteronism: a Systematic Review and Meta-Analysis.

Authors:  Alexander A Leung; Christopher J Symonds; Gregory L Hundemer; Paul E Ronksley; Diane L Lorenzetti; Janice L Pasieka; Adrian Harvey; Gregory A Kline
Journal:  Hypertension       Date:  2022-06-02       Impact factor: 9.897

3.  The value of the post-captopril aldosterone/renin ratio for the diagnosis of primary aldosteronism and the influential factors: A meta-analysis.

Authors:  Qiao Xiang; Wen Wang; Tao Chen; Kai Yu; Qianrui Li; Tingting Zhang; Haoming Tian; Yan Ren
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Oct-Dec       Impact factor: 1.636

4.  Age-Related Cutoffs of Plasma Aldosterone/Renin Concentration for Primary Aldosteronism Screening.

Authors:  Linqiang Ma; Ying Song; Mei Mei; Wenwen He; Jinbo Hu; Qingfeng Cheng; Ziwei Tang; Ting Luo; Yue Wang; Qianna Zhen; Zhihong Wang; Hua Qing; Yihong He; Qifu Li; Shumin Yang
Journal:  Int J Endocrinol       Date:  2018-07-16       Impact factor: 3.257

5.  Clinical and biochemical predictors and predictive model of primary aldosteronism.

Authors:  Worapaka Manosroi; Natthanan Tacharearnmuang; Pichitchai Atthakomol
Journal:  PLoS One       Date:  2022-08-05       Impact factor: 3.752

6.  The Association between eGFR and the Aldosterone-to-Renin Ratio and Its Effect on Screening for Primary Aldosteronism.

Authors:  Jing Xu; Yumei Yang; Yan Ling; Zhiqiang Lu; Xin Gao; Xiaomu Li; Xiaoying Li
Journal:  Int J Endocrinol       Date:  2020-02-07       Impact factor: 3.257

7.  Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism.

Authors:  Aya Saiki; Michio Otsuki; Kosuke Mukai; Reiko Hayashi; Iichiro Shimomura; Isao Kurihara; Takamasa Ichijo; Yoshiyu Takeda; Takuyuki Katabami; Mika Tsuiki; Norio Wada; Yoshihiro Ogawa; Junji Kawashima; Masakatsu Sone; Nobuya Inagaki; Takanobu Yoshimoto; Ryuji Okamoto; Katsutoshi Takahashi; Hiroki Kobayashi; Kouichi Tamura; Kohei Kamemura; Koichi Yamamoto; Shoichiro Izawa; Miki Kakutani; Masanobu Yamada; Akiyo Tanabe; Mitsuhide Naruse
Journal:  J Endocr Soc       Date:  2020-02-13

Review 8.  Confounders of the aldosterone-to-renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature.

Authors:  Gregory P Veldhuizen; Rawan M Alnazer; Abraham A Kroon; Peter W de Leeuw
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-27       Impact factor: 3.738

9.  The Value of Different Single or Combined Indexes of the Captopril Challenge Test in the Diagnosis of Primary Aldosteronism.

Authors:  Qiao Xiang; Tao Chen; Kai Yu; Yuanmei Li; Qianrui Li; Haoming Tian; Yan Ren
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.